Öksüz, Z.; Gragnani, L.; Lorini, S.; Temel, G.Ö.; Serin, M.S.; Zignego, A.L.
Evaluation of Plasma miR-17-5p, miR-24-3p and miRNA-223-3p Profile of Hepatitis C Virus-Infected Patients after Treatment with Direct-Acting Antivirals. J. Pers. Med. 2023, 13, 1188.
https://doi.org/10.3390/jpm13081188
AMA Style
Öksüz Z, Gragnani L, Lorini S, Temel GÖ, Serin MS, Zignego AL.
Evaluation of Plasma miR-17-5p, miR-24-3p and miRNA-223-3p Profile of Hepatitis C Virus-Infected Patients after Treatment with Direct-Acting Antivirals. Journal of Personalized Medicine. 2023; 13(8):1188.
https://doi.org/10.3390/jpm13081188
Chicago/Turabian Style
Öksüz, Zehra, Laura Gragnani, Serena Lorini, Gülhan Örekici Temel, Mehmet Sami Serin, and Anna Linda Zignego.
2023. "Evaluation of Plasma miR-17-5p, miR-24-3p and miRNA-223-3p Profile of Hepatitis C Virus-Infected Patients after Treatment with Direct-Acting Antivirals" Journal of Personalized Medicine 13, no. 8: 1188.
https://doi.org/10.3390/jpm13081188
APA Style
Öksüz, Z., Gragnani, L., Lorini, S., Temel, G. Ö., Serin, M. S., & Zignego, A. L.
(2023). Evaluation of Plasma miR-17-5p, miR-24-3p and miRNA-223-3p Profile of Hepatitis C Virus-Infected Patients after Treatment with Direct-Acting Antivirals. Journal of Personalized Medicine, 13(8), 1188.
https://doi.org/10.3390/jpm13081188
